In last trading session, Aytu BioPharma Inc (NASDAQ:AYTU) saw 3.67 million shares changing hands with its beta currently measuring -0.08. Company’s recent per share price level of $1.35 trading at $0.04 or 3.05% at ring of the bell on the day assigns it a market valuation of $8.33M. That closing price of AYTU’s stock is at a discount of -155.56% from its 52-week high price of $3.45 and is indicating a premium of 29.63% from its 52-week low price of $0.95. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.48 million shares which gives us an average trading volume of 35.17K if we extend that period to 3-months.

Aytu BioPharma Inc (NASDAQ:AYTU) trade information

Upright in the green during last session for gaining 3.05%, in the last five days AYTU remained trading in the green while hitting it’s week-highest on Wednesday, 05/14/25 when the stock touched $1.35 price level, adding 3.57% to its value on the day. Aytu BioPharma Inc’s shares saw a change of -20.59% in year-to-date performance and have moved 11.57% in past 5-day. Aytu BioPharma Inc (NASDAQ:AYTU) showed a performance of 35.00% in past 30-days. Number of shares sold short was 0.14 million shares which calculate 3.84 days to cover the short interests.

Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 66.68% during past 5 years.

Aytu BioPharma Inc (NASDAQ:AYTU)’s Major holders

Insiders are in possession of 2.81% of company’s total shares while institution are holding 30.80 percent of that, with stock having share float percentage of 31.69%. Investors also watch the number of corporate investors in a company very closely, which is 30.80% institutions for Aytu BioPharma Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund are the top two Mutual Funds which own company’s shares. As of Mar 31, 2025 , the former fund manager was holding 32.37 shares of worth $43702.0 or 0.52% of the total outstanding shares. The later fund manager was in possession of 27.89 shares on Dec 31, 2024 , making its stake of worth around $37648.0 in the company or a holder of 0.45% of company’s stock.